Yale School Of Medicine
Data question universal restriction of vigorous exercise for people with HCM
NEW ORLEANS — Adults with hypertrophic cardiomyopathy who engaged in vigorous exercise were at no greater risk for death, cardiac arrest or other outcomes compared with those engaging in low-to-moderate-intensity physical activity.
Self-expanding TAVR system shows durable benefits in low-risk patients at 3 years
NEW ORLEANS — At 3 years, patients with severe aortic stenosis at low surgical risk who had transcatheter aortic valve replacement with a self-expanding valve continued to have lower risk for death or stroke than those who had surgical AVR.
All-cause, CVD mortality highest in Black patients among those with cancer
Researchers observed significant racial disparities in all-cause and CVD mortality among adults with cancer, with wider gaps found among patients younger than 55 years, according to a study published in JACC: CardioOncology.
Sacituzumab govitecan induces response in cisplatin-ineligible urothelial carcinoma
SAN FRANCISCO — Sacituzumab govitecan induced response among one-third of platinum-ineligible patients with metastatic urothelial carcinoma whose disease progressed after checkpoint inhibitor therapy, according to study results.
A tribute to Barry L. Zaret, MD
Cardiology Today Editorial Board Member Barry L. Zaret, MD, MASNC, a pioneer in the field of nuclear cardiology, recently passed away, the American Society for Nuclear Cardiology announced.
Yale School of Medicine establishes cannabis, cannabinoids research center
Yale School of Medicine has established a research center to examine the association of cannabis and cannabinoids with neurodevelopment and mental health, the school announced in a press release.
Simulations of college campus mpox outbreaks show importance of detection, isolation
Future outbreaks of mpox on college campuses could be contained with timely detection and isolation of symptomatic cases, a study found.
Survival gains with checkpoint inhibitors differ ‘drastically’ between age groups in NSCLC
Despite significantly extending survival for younger adults with advanced non-small cell lung cancer, immune checkpoint inhibitors have conferred only modest OS gains over time among patients aged older than 75 years, study results showed.
ISPAD guideline updates: Insulin delivery, psychological care, nutrition and more
The 2022 International Society for Pediatric and Adolescent Diabetes guidelines include updates on insulin delivery, psychological care and nutritional management for children, adolescents and young people with diabetes.
Gene therapy may be equitable therapeutic option for sickle cell disease in US
Gene therapy could represent an equitable therapeutic strategy for sickle cell disease in the United States, according to study results presented at ASH Annual Meeting and Exposition.